Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population (original) (raw)

Prospective Study

Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.

World J Gastroenterol. Oct 14, 2014; 20(38): 14010-14017
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.14010

Table 4 Correlation between Apolipoprotein C3 (-455T>C) polymorphism and hypertension, dyslipidemia in the nonalcoholic fatty liver disease group n (%)

Genotype Metabolic component P value Adjusted OR (95%CI)
Non-hypertension Hypertension
TT 82 (34.7) 12 (18.8) - 1
TC 102 (43.2) 29 (45.3) 0.041 2.16 (1.02-4.57)1
CC 52 (22.1) 23 (35.9) 0.0032 3.42 (1.53-7.60)2
Non-hypertriglyceridemia Hypertriglyceridemia
TT 71 (39.3) 23 (19.3) - 1
TC 77 (42.5) 54 (45.4) 0.021 2.03 (1.12-3.68)1
CC 33 (18.2) 42 (35.3) < 0.0012 3.80 (1.95-7.41)2
Normal HDL Low HDL
TT 63 (36.6) 31 (24.2) - 1
TC 75 (43.6) 56 (43.8) 0.301 1.36 (0.76 -2.42)1
CC 34 (19.8) 41 (32.0) 0.012 2.34 (1.21 -4.52)2
Non-hypercholesterolemia Hypercholesterolemia
TT 57 (32.0) 37 (30.3) - 1
TC 81 (45.5) 50 (41.0) 0.521 -
CC 40 (22.5) 35 (28.7) 0.202 -
Normal LDL Increased LDL
TT 65 (31.0) 29 (32.2) - 1
TC 89 (42.3) 42 (46.7) 0.411 -
CC 56 (26.7) 19 (21.1) 0.332 -